The Medical Exchange may seek out private placements to continue operations

By Sheri Kasprzak

New York, Feb. 14 - The Medical Exchange Inc. said it may head to the PIPE market this year to fund its ongoing operations.

In the company's latest 10-QSB filed with the Securities and Exchange Commission, The Medical Exchange said it is pursuing financing alternatives to meet its needs.

"We are pursuing various financing alternatives to meet our immediate and long-term financial requirements, which we anticipate will consist of further private placements of equity securities or shareholder loans," said the report.

"There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our obligations as they become due and we will be forced to scale down or perhaps even cease our operations."

For the period from Sept. 30 to Dec. 31, The Medical Exchange generated no revenue.

"Total operating expenses for the period from Sept. 30, 2005 to Dec. 31, 2005 were $3,101," the report said.

For the same period ended Dec. 31, 2004, the company reported a net loss of $8,545.

Based in Saskatoon, Sask., The Medical Exchange is a biotechnology company focused on human therapeutic drugs, DNA diagnostics and pharmaceutical discovery.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.